Evidence map›Paper›PMID 33062429›Full record

ArticlePeerJ2020

Anna Rzucidło-Hymczak, Hubert Hymczak, Aldona Olechowska-Jarząb, Anna Gorczyca, Boguslaw Kapelak, Rafał Drwiła, Dariusz Plicner

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PeerJ, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Diabetes Mellitus and the Risk and Outcomes ofInfection and drug resistance · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Anna Rzucidło-HymczakDepartment of Infectious Diseases, John Paul II Hospital, Krakow, Poland.
Hubert HymczakDepartment of Anesthesiology, John Paul II Hospital, Krakow, Poland.
Aldona Olechowska-JarząbDepartment of Microbiology, John Paul II Hospital, Krakow, Poland.
Anna GorczycaDepartment of Infectious Diseases, John Paul II Hospital, Krakow, Poland.
Boguslaw KapelakDepartment of Cardiovascular Surgery and Transplantology, John Paul II Hospital, Krakow, Poland.
Rafał DrwiłaMedical College, Jagiellonian University, Krakow, Poland.
Dariusz PlicnerUnit of Experimental Cardiology and Cardiac Surgery, Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, Krakow, Poland.
John Paul II Hospital · PLAndrzej Frycz Modrzewski Krakow University · PLJagiellonian University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundClostridioides difficile infection (CDI) is the most common cause of hospital-acquired diarrhea. There is little available data regarding risk factors of CDI for patients who undergo cardiac surgery. The study evaluated the course of CDI in patients after cardiac surgery.

methodsOf 6,198 patients studied, 70 (1.1%) developed CDI. The control group consisted of 73 patients in whom CDI was excluded. Perioperative data and clinical outcomes were analyzed.

resultsPatients with CDI were significantly older in comparison to the control group (median age 73.0 vs 67.0,

conclusionsThe study did not reveal any specific cardiac surgery-related risk factors for development of CDI.

Indexed as

Cardiac surgeryClostridioides difficile infectionRisk factors

Identifiers

PMID33062429
PMCPMC7531357
OpenAlexW3090354830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.